Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ER-Negative PR-Negative HER2-Negative Breast Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04675827
What this trial is testing

De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 Blockade

Who this might be right for
HER2-positive Breast CancerER-Negative Breast CancerPR-Negative Breast Cancer+1 more
Jules Bordet Institute 139
Testing effectiveness (Phase 2)Looking for participantsNCT04683679
What this trial is testing

Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerTNBC - Triple-Negative Breast CancerBreast Cancer+1 more
Memorial Sloan Kettering Cancer Center 34
Testing effectiveness (Phase 2)Looking for participantsNCT06492005
What this trial is testing

A Clinical Study of 9MW2821 (and PD-1 Inhibitor) in Locally Advanced or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer
Mabwell (Shanghai) Bioscience Co., Ltd. 160
Testing effectiveness (Phase 2)Looking for participantsNCT07188246
What this trial is testing

Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast CancerBreast Cancer Stage IIBreast Cancer Stage III+2 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 40
Testing effectiveness (Phase 2)Study completedNCT00546156
What this trial is testing

Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer

Who this might be right for
Breast Cancer
Ian E. Krop, MD, PhD 104
Not applicableLooking for participantsNCT07311083
What this trial is testing

Feasibility of a Lifestyle Intervention for Women With Triple-negative Breast Cancer Under Neoadjuvant Immunotherapy

Who this might be right for
Microbiome
Kliniken Essen-Mitte 60
Testing effectiveness (Phase 2)Study completedNCT02423603
What this trial is testing

PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Queen Mary University of London 71
Early research (Phase 1)Study completedNCT01351103
What this trial is testing

LGK974 in Patients With Malignancies Dependent on Wnt Ligands

Who this might be right for
Pancreatic CancerBRAF Mutant Colorectal CancerMelanoma+5 more
Novartis Pharmaceuticals 185
Post-approval studies (Phase 4)UnknownNCT03799679
What this trial is testing

Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Fudan University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06534762
What this trial is testing

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

Who this might be right for
NSCLCSCLCColorectal Cancer+4 more
Zhejiang Provincial People's Hospital 260
Early research (Phase 1)WithdrawnNCT06229392
What this trial is testing

Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer

Who this might be right for
Breast CancerBreast Cancer Triple Negative
Rush University Medical Center
Testing effectiveness (Phase 2)Study completedNCT02789332
What this trial is testing

Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency

Who this might be right for
Breast CancerTriple Negative Breast NeoplasmsHRpos Breast Neoplasms+1 more
GBG Forschungs GmbH 107
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06849492
What this trial is testing

HIM Typing Guides the Treatment of Advanced First-Line Triple-Negative Breast Cancer

Who this might be right for
Advanced Triple Negative Breast Cancer
Fudan University 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05128734
What this trial is testing

Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)

Who this might be right for
Breast Cancer Triple Negative
AHS Cancer Control Alberta 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05821686
What this trial is testing

Efficacy of Interleukin-2 in Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Nova Scotia Health Authority 10
Testing effectiveness (Phase 2)Study completedNCT03304756
What this trial is testing

Study of Neoadjuvant Treatment of Locally Advanced Breast Cancer With CAP Regimen

Who this might be right for
Triple Negative Breast Cancer Patients
Instituto Nacional de Cancer, Brazil 41
Early research (Phase 1)UnknownNCT02637531
What this trial is testing

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

Who this might be right for
Advanced Solid Tumors (Part A/B/C/D)Non-small Cell Lung Cancer (Part E)Melanoma (Part E)+5 more
Infinity Pharmaceuticals, Inc. 219
Not applicableUnknownNCT03920488
What this trial is testing

Next-Generation Sequencing-based Germline and Somatic Genetic Testing in Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
European Institute of Oncology 264
Testing effectiveness (Phase 2)WithdrawnNCT03982173
What this trial is testing

Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors

Who this might be right for
Metastatic Colorectal CancerTriple Negative Breast CancerProstate Adenocarcinoma+2 more
Gustave Roussy, Cancer Campus, Grand Paris
Large-scale testing (Phase 3)WithdrawnNCT02201381
What this trial is testing

Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer

Who this might be right for
CancerOverall Survival
Health Clinics Limited
Next Page